• Arun Sharma
  • Anikate Sood
  • Vineet Mehta
  • Udayabanu Malairaman Jaypee University of Information Technology, Waknaghat, Himachal Pradesh, India-173234.


Objective: The purpose of this research was to formulate nanostructured lipid carrier system (NLCs) in such a way that they can be applied for
bacterial as well as fungal infectious diseases.
Methods: To achieve the prime objective, varying concentrations of clotrimazole (CLZ) and ciprofloxacin (CIPRO) were selected for formulations.
Stearic acid (solid lipid polymer), oleic acid (liquid lipid polymer), and polyvinyl alcohol (surfactant) were utilized for formulating NLCs through
solvent diffusion technique. NLCs were characterized for their surface morphology, Fourier transform infrared spectroscopy (FTIR) drug-polymer
interaction, particle size distribution, zeta potential, loading capacity, drug entrapment efficacy (EE), and in vitro drug release profile.
Results: NLCs were fabricated with size range varying from 276 nm to 564 nm, possessing smooth spherical morphology. No drug-polymer interaction
was observed through FTIR analysis. The highest drug EE for CLZ and CIPRO was found to be 78.6% and 65.8%, respectively. Formulated NLCs depict
the biphasic release profile with initial burst release of 40% within 2 hrs followed by controlled release.
Conclusion: Better homing of drug molecules and controlled drug release through formulated NLCs makes them suitable carrier system for various
anti-microbial and anti-fungal applications.
Keywords: Nanostructured lipid carries, Clotrimazole, Ciprofloxacin, Solvent diffusion method, In vitro release.


Download data is not yet available.



Angelova A, Angelov B, Mutafchieva R, Lesieur S, Couvreur P.

Self-assembled multicompartment liquid crystalline lipid carriers

for protein, peptide, and nucleic acid drug delivery. Acc Chem Res


Martins S, Sarmento B, Ferreira DC, Souto EB. Lipid-based colloidal

carriers for peptide and protein delivery – Liposomes versus lipid

nanoparticles. Int J Nanomedicine 2007;2(4):595-607.

Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for

controlled drug delivery - A review of the state of the art. Eur J Pharm

Biopharm 2000;50(1):161-77.

Weyhers H, Ehlers S, Hahn H, Souto EB, Müller RH. Solid lipid

nanoparticles (SLN) – Effects of lipid composition on in vitro

degradation and in vivo toxicity. Pharmazie 2006;61(6):539-44.

Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN)

and nanostructured lipid carriers (NLC) in cosmetic and dermatological

preparations. Adv Drug Deliv Rev 2002;54 Suppl 1:S131-55.

Uner M. Preparation, characterization and physico-chemical properties

of solid lipid nanoparticles (SLN) and nanostructured lipid carriers



(NLC): Their benefits as colloidal drug carrier systems. Pharmazie


Müller RH, Radtke M, Wissing SA. Nanostructured lipid

matrices for improved microencapsulation of drugs. Int J Pharm


Nguyen TK, Selvanayagam R, Ho KK, Chen R, Kutty SK, Rice SA,

et al. Co-delivery of nitric oxide and antibiotic using polymeric

nanoparticles. Chem Sci 2016;7:1016-27.

Jarvis WR. Epidemiology of nosocomial fungal infections, with

emphasis on Candida species. Clin Infect Dis 1995;20(6):1526-30.

Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections.

Clin Microbiol Rev 1996;9(4):499-511.

Kunimoto DY, Sharma S, Garg P, Rao GN. In vitro susceptibility

of bacterial keratitis pathogens to ciprofloxacin: Emerging

resistance11The authors have no proprietary interest in any aspect of

this study. Ophthalmology 1999;106:80-5.

Paladino JA, Sperry HE, Backes JM, Gelber JA, Serrianne DJ,

Cumbo TJ, et al. Clinical and economic evaluation of oral ciprofloxacin

after an abbreviated course of intravenous antibiotics. Am J Med


Jeong YI, Na HS, Seo DH, Kim DG, Lee HC, Jang MK,

et al. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide)

nanoparticles and its antibacterial activity. Int J Pharm


Talan DA, Naber KG, Palou J, Elkharrat D. Extended-release

ciprofloxacin (Cipro XR) for treatment of urinary tract infections. Int J

Antimicrob Agents 2004;23 Suppl 1:S54-66.

Das S, Ng WK, Tan RB. Are nanostructured lipid carriers (NLCs) better

than solid lipid nanoparticles (SLNs): Development, characterizations

and comparative evaluations of clotrimazole-loaded SLNs and NLCs?

Eur J Pharm Sci 2012;47:139-51.

Zuber TJ, Baddam K. Superficial fungal infection of the skin.

Where and how it appears help determine therapy. Postgrad Med

;109(1):117-20, 123-6, 131-2.

Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S. Preparation and

characterization of stearic acid nanostructured lipid carriers by solvent

Asian J Pharm Clin Res, Vol 9, Issue 3, 2016, 356-360

Sharma et al.

diffusion method in an aqueous system. Coll Surf B Biointerfaces


Sareen R, Bhardwaj V, Mehta V, Sharma A. Topical gel incorporated

with non-ionic surfactant based solid lipid microspheres of ketoprofen:

Physicochemical analysis and anti-inflammatory evaluation. Int J

Pharm Pharm Sci 2015;7(11):200-6.

Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ,

Hussain SM. Characterization of nanomaterial dispersion in solution

prior to in vitro exposure using dynamic light scattering technique.

Toxicol Sci 2008;101(2):239-53.

Araújo J, Gonzalez-Mira E, Egea MA, Garcia ML, Souto EB.

Optimization and physicochemical characterization of a triamcinolone

acetonide-loaded NLC for ocular antiangiogenic applications. Int J

Pharm 2010;393(1-2):167-75.



How to Cite

Sharma, A., A. Sood, V. Mehta, and U. Malairaman. “FORMULATION AND PHYSICOCHEMICAL EVALUATION OF NANOSTRUCTURED LIPID CARRIER FOR CODELIVERY OF CLOTRIMAZOLE AND CIPROFLOXACIN”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 3, May 2016, pp. 356-60,



Original Article(s)